Inflammatory Bowel Diseases 2010 5th Congress of ECCO - the European Crohn's and Colitis Organisation
February 25, 2010 - February 27, 2010
| Prague
The webcasts of this meeting, held in Prague, Czech Rebublic, from February 25th to 27th, provide access to the latest and best scientific information in Inflammatory Bowel Disease. Structured in basic science and clinical sections, the advances in the understanding of the pathophysiology of these complex disorders, the improvements and developments of evidence-based guidelines and the definition of better outcome parameters for therapy are addressed.
Presentations
Smad7 expression in T cells protects from colitis-associated colorectal cancer Fibrogenesis and its consequences
February 25, 2010 13:30 | Length: 10:24 min
Congress: Inflammatory Bowel Diseases 2010
Markers of fibrosis in practice: Is this stricture inflammatory? Fibrogenesis and its consequences
February 25, 2010 13:40
Congress: Inflammatory Bowel Diseases 2010
Oxygen sensor inhibition attenuates TNF-?-induced intestinal epithelial damage by hypoxia-inducible factor (HIF)-1-dependent repression of fas-associated death domain protein (FADD) Fibrogenesis and its consequences
February 25, 2010 14:00
Congress: Inflammatory Bowel Diseases 2010
Therapeutic opportunities for modifying fibrosis: lessons from the liver Fibrogenesis and its consequences
February 25, 2010 14:20
Congress: Inflammatory Bowel Diseases 2010
Modulation of gut immune homeostasis via the Toll-interacting protein Extraintestinal manifestations
February 25, 2010 15:30
Congress: Inflammatory Bowel Diseases 2010
PSC and prognosis Extraintestinal manifestations
February 25, 2010 15:40
Congress: Inflammatory Bowel Diseases 2010
Genetic variants that predispose to early complications in Crohn’s disease identified by re-analysing genome-wide association study data from 3 consortia Extraintestinal manifestations
February 25, 2010 16:00
Congress: Inflammatory Bowel Diseases 2010
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis Extraintestinal manifestations
February 25, 2010 16:20
Congress: Inflammatory Bowel Diseases 2010
Oral treatment using Parabacteroides distasonis components attenuates dextran sodium sulphate induced colitis by modulation of immunity and microbiota composition Therapeutic opportunity: Leukocyte Trafficking
February 26, 2010 09:00
Congress: Inflammatory Bowel Diseases 2010
Future present: traffic control Therapeutic opportunity: Leukocyte Trafficking
February 26, 2010 09:30
Congress: Inflammatory Bowel Diseases 2010
Pharmaco-economic impact of mucosal healing in early Crohn’s disease: an analysis of the step-up-top-down prospective follow-up study Endpoints and outcomes of therapy
February 26, 2010 11:30
Congress: Inflammatory Bowel Diseases 2010
Chronic granulomatous disease It's not always IBD
February 26, 2010 13:30
Congress: Inflammatory Bowel Diseases 2010
Clinical and biological efficacy to anti-TNF therapy relates to reciprocally modulating blood and intestinal mucosa Foxp3 expression It's not always IBD
February 26, 2010 13:50
Congress: Inflammatory Bowel Diseases 2010
TB or not TB? It's not always IBD
February 26, 2010 14:00
Congress: Inflammatory Bowel Diseases 2010
Deep remission for adalimumab-treated patients with moderate to severe ileocolonic Crohn’s disease: Results from EXTEND It's not always IBD
February 26, 2010 14:30
Congress: Inflammatory Bowel Diseases 2010
Liver histology of IBD patients who are treated with 6-thioguanine due to failure of conventional thiopurines Safety in IBD therapy
February 26, 2010 15:50
Congress: Inflammatory Bowel Diseases 2010
Long- term outcome of treatment with infliximab in paediatric Crohn's disease : a population-based study Safety in IBD therapy
February 26, 2010 16:30
Congress: Inflammatory Bowel Diseases 2010
Travelling with IBD Safety in IBD therapy
February 26, 2010 16:40
Congress: Inflammatory Bowel Diseases 2010
Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study Intestinal failure
February 27, 2010 08:50
Congress: Inflammatory Bowel Diseases 2010
Predictors of intestinal failure in inflammatory bowel disease Intestinal failure
February 27, 2010 09:30
Congress: Inflammatory Bowel Diseases 2010
Hide and seek - CMV in IBD Challenging Cases
February 27, 2010 10:00
Congress: Inflammatory Bowel Diseases 2010
An unusual mediastinal complication during anti-TNF treatment Challenging Cases
February 27, 2010 10:20
Congress: Inflammatory Bowel Diseases 2010
Severe hypoalbuminemia in a patient with long duration Crohn's disease treated with Infliximab Challenging Cases
February 27, 2010 10:40
Congress: Inflammatory Bowel Diseases 2010
Infos
| Date | February 25, 2010 - February 27, 2010 |
|---|---|
| Program-Link: | http://ecco10.ecco-ibd.eu/programme/overview.php?navId=254 |
| Website: | http://ecco10.ecco-ibd.eu/ |
| Location: | Prague; |
| Organizer: | ECCO Secretariat; |
| Category: | Medicine; |
Partner Societies
Content of the webcasts is the view and comment of the speakers or author and not of sponsoring companies or organisations. Organisation logo does not indicate endorsement.
European Crohn's and Colitis Organization
Spanish Society of Internal Medicine
Austrian Crohn's and Colitis Ulcerosa Association
Latest Presentations
Please activate JavaScript to see this video.
Sponsors
Videos are not working? If the videos are not working on your computer, make sure you have javascript enabled in your browser.
Trending Content Box
The 10 MOST VISITED WEBCASTS in April, 2013
- Should recently approved antiepileptic drugs be used early in the treament of epilepsy? the answer is no. By Prof. E. Beghi
- Dimethyl Fumarate by Prof. Jacek Losy
- Complete Mesocolic Excision: a way to standardize Colon Cancer Surgery by Prof. Werner Hohenberger
- Agents targeting the mTOR-PI3K-Akt pathway by Prof. J. Tabernero
- Prostate specific membrane antigen antibody drug conjugate PSMA ADC): a phase 1 trial in castration-resistant metastatic prostate cancer by Prof. D. Petrylak
- Bone marrow stem cell transplantation in mulitple sclerosis by Prof. D. Karussis
- Secretomics of endometrial fluid for non-invasive assessment of endometrial receptivity by Prof. Nick Macklon
- The global epidemiology of syphilis and the challenges and opportunities to address maternal and congenital syphilis by Prof. F. Ndow
- Adalimumab for induction of clinical remission in moderately to severe active ulceratice colitis by Prof. W. Reinisch
- Current management of AIN3 and cancer by Prof. S. Goldstone
Latest Congresses
April 07, 2013
February 24, 2013
March 15, 2012
November 17, 2011
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our Terms of use. Warning: Some websites may contain content of an adult nature. These pages are designed for ADULTS only.